CPC technology class · C12
C12N - Microorganisms OR Enzymes
Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media. 68,530 US utility patents granted 2015–2025, with the leading assignees and year-by-year filing trajectory.
- 68,530
- US patents granted
- C12
- Parent CPC class
- 20
- Active assignees
- +23%
- 5-yr velocity
The verdict
Microorganisms OR Enzymes ranks #20 of 670 CPC technology areas - 68,530 US patents granted since 2015, with filing up 23% over five years.
- #20
- of 670 CPC technology areas
- 68,530
- US patents granted, 2015–2025
- Monsanto Technology
- leading assignee (1,335)
- +23%
- filing velocity, last 5 yrs
CPC subclass C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA - covers 68,530 US utility patents granted between 2015 and 2025 according to USPTO PatentsView records, within the broader CPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). See our CPC classification guide for how the system works.
The competitive landscape in C12N is shaped by 20 distinct companies actively filing in this space. Monsanto Technology Llc leads with 1,335 patents, followed by The Regents Of The University Of California at 1,161 grants and Novozymes A/s at 656.
Filing activity in C12N is up 23% over the past five years versus 2015-2019, a sharp acceleration suggesting an emerging or fast-moving technology area. All counts come directly from USPTO PatentsView and reflect US granted utility patents only.
Is C12N innovation accelerating?
US utility-patent grants per year in C12N, 2015–2025 - recent five years are up 23% versus 2015–2019.
Who leads C12N?
The 12 most active assignees in MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA - wider bars mean more grants
- Monsanto Technology
Monsanto Technology LLC
1,335 patents
- The Regents of the Un…
The Regents of the University of California
1,161 patents
- Novozymes A/S
Novozymes A/S
656 patents
- Immatics Biotechnolog…
Immatics Biotechnologies GmbH
647 patents
- Pioneer Hi-bred Inter…
PIONEER HI-BRED INTERNATIONAL, INC.
623 patents
- President and Fellows…
President and Fellows of Harvard College
594 patents
- Massachusetts Institu…
Massachusetts Institute of Technology
541 patents
- The Trustees of the U…
The Trustees of the University of Pennsylvania
537 patents
- Regeneron Pharmaceuti… 458
REGENERON PHARMACEUTICALS, INC.
458 patents
- The Board of Trustees… 442
The Board of Trustees of the Leland Stanford Junior University
442 patents
- The United States of… 431
The United States of America, as represented by the Secretary, Department of Health and Human Services
431 patents
- Centre National De La… 398
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
398 patents
What this shows Monsanto Technology is the most active filer in C12N, holding 1,335 of the 68,530 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in C12N |
|---|---|---|
| #1 | Monsanto Technology Llc | 1,335 |
| #2 | The Regents Of The University Of California | 1,161 |
| #3 | Novozymes A/s | 656 |
| #4 | Immatics Biotechnologies Gmbh | 647 |
| #5 | Pioneer Hi-bred International, Inc. | 623 |
| #6 | President And Fellows Of Harvard College | 594 |
| #7 | Massachusetts Institute Of Technology | 541 |
| #8 | The Trustees Of The University Of Pennsylvania | 537 |
| #9 | Regeneron Pharmaceuticals, Inc. | 458 |
| #10 | The Board Of Trustees Of The Leland Stanford Junior University | 442 |
| #11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 431 |
| #12 | Centre National DE LA Recherche Scientifique | 398 |
| #13 | The Board Of Regents Of The University Of Texas System | 358 |
| #14 | Wisconsin Alumni Research Foundation | 358 |
| #15 | Codexis, Inc. | 346 |
| #16 | University Of Massachusetts | 299 |
| #17 | Syngenta Participations Ag | 296 |
| #18 | The General Hospital Corporation | 295 |
| #19 | Alnylam Pharmaceuticals, Inc. | 262 |
| #20 | DSM IP Assets B.v. | 257 |
About This Class
CPC subclass C12N belongs to class C12.
68,530 patents were granted in this class between 2015 and 2025.
20 companies actively patent in this space.
Classification System
Cooperative Patent Classification (CPC) is a hierarchical patent classification system used by the USPTO and EPO.
Footprint here vs. claim strategy
Each dot is a leading C12N assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Top 14 C12N assignees by class footprint. Bubble size = patents in C12N. Source: USPTO PatentsView (claim depth is company-wide across all classes).
Frequently Asked Questions
What is CPC class C12N?
How many patents have been filed in C12N?
Which company holds the most patents in C12N?
How is patent data for C12N collected?
What is the difference between CPC class and subclass?
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.